E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/5/2020 in the Prospect News Distressed Debt Daily.

Vivus seeks 75-day exclusivity extension to finalize settlement terms

By Sarah Lizee

Olympia, Wash., Nov. 5 – Vivus, Inc. is seeking a 75-day extension of its exclusive periods to file and solicit votes on a Chapter 11 plan, according to a motion filed Wednesday in the U.S. Bankruptcy Court for the District of Delaware.

The company is asking the court to extend the plan filing period through Jan. 18 from Nov. 4 and the solicitation period through March 19 from Jan. 3.

The debtors said they are seeking the extension to finalize and implement the settlement among the debtors, the equity committee and IEH Biopharma LLC following successful mediation over the weekend.

Terms of the settlement will be outlined in a revised plan of reorganization, which Vivus said will be filed shortly.

A hearing is scheduled for Nov. 19.

Campbell, Calif.-based Vivus is a pharmaceutical company that filed bankruptcy on July 7. The Chapter 11 case number is 20-11779.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.